FIELD: medicine. SUBSTANCE: invention relates to application of β-(3,5-di-tert. -butyl-4-hydroxyphenyl)-propionic acid or its potassium salt as antiepileptic agent with nootropic effect. The proposed invention has no adverse effects and allows to improve memory, teaching capacity and fundamental rational activity and can be used for treatment of patients with epilepsy. EFFECT: valuable medicinal properties of agent. 1 cl, 3 dwg, 4 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PAROXYSMAL CONDITIONS | 2011 |
|
RU2469722C1 |
| METHOD OF DETECTING ANTICONVULSANT ACTION OF SODIUM CITICOLINE AND VALPROATE WHEN APPLYING THEM TOGETHER ON MODEL OF ACUTE GENERALIZED CONVULSIONS CAUSED BY PENTYLENETETRAZOLE IN WISTAR MALE RATS | 2015 |
|
RU2600477C1 |
| METHOD OF MODELLING PAROXYSMAL CONVULSIVE DISORDER | 2009 |
|
RU2434306C2 |
| COFORMULATED DRUGS CONTAINING 2-ETHYL-3-(N,N-DIMETHYLCARBAMOYLOXY)-6-METHYLPYRIDINE SALTS WITH ORGANIC AND INORGANIC ACIDS AND SUCCINIC ACID SHOWING ANTIHYPOXIC, ANTIAMNESTIC AND ANTICONVULSANT ACTIVITY | 2009 |
|
RU2440115C2 |
| COUMARIN, THIOCOUMARIN AND QUINOLINONE DERIVATIVES, HAVING ANTICONVULSANT ACTIVITY | 2017 |
|
RU2720510C2 |
| AGENT POSSESSING ANXIOLYTIC, NOOTROPIC, ANTICONVULSANT, ANTIDEPRESSIVE, CEREBRO-PROTECTING ACTIVITY AND ABILITY TO NORMALISE TRANSFER PROCESSES IN BRAIN SYNAPSES | 2007 |
|
RU2335293C1 |
| NOOTROPIC ANTIALCOHOLIC DRUG | 1985 |
|
RU2020937C1 |
| ANTICONVULSANT AND ANTIHYPOXIC AGENT | 2008 |
|
RU2393857C2 |
| 4-BENZOYLPYRIDINE OXIME DERIVATIVES HAVING ANTICONVULSANT ACTIVITY AS AGENTS FOR TREATMENT OF EPILEPSY AND PAROXYSMAL STATES | 2016 |
|
RU2643091C2 |
| METHOD FOR DISCOVERING ANTICONVULSANT ACTION OF CITICOLINE IN PENTYLENETETRAZOLE KINDLING MODEL INVOLVING MALE C57B1/6 MICE | 2014 |
|
RU2567275C1 |
